Elpinan

Elpinan Uses, Dosage, Side Effects, Food Interaction and all others data.

Elpinan is a topically active antihistamine that antagonizes both histamine H1 and H2 receptors. Moreover, it has mast cell stabilizing activity and prevents the release of inflammatory mediators from blood vessel. Elpinan does not penetrate the blood-brain barrier and therefore is not expected to induce side effects of the central nervous system.

Elpinan is an antihistamine and an inhibitor of histamine release from the mast cell for topical administration to the eyes. Elpinan is indicated for the prevention of itching associated with allergic conjunctivitis. Elpinan is a topically active, direct H1-receptor antagonist and an inhibitor of the release of histamine from the mast cell. Elpinan is selective for the histamine H1-receptor and has affinity for the histamine H2 receptor. Elpinan also possesses affinity for the a1-, a2-, and 5-HT2 -receptors. Elpinan does not penetrate the blood/brain barrier and, therefore, is not expected to induce side effects of the central nervous system.

Trade Name Elpinan
Availability Prescription only
Generic Epinastine
Epinastine Other Names Epinastin, Epinastina, Epinastine, épinastine, Epinastinum
Related Drugs prednisone, cetirizine ophthalmic, dexamethasone ophthalmic, prednisolone ophthalmic, azelastine ophthalmic, doxylamine
Type
Formula C16H15N3
Weight Average: 249.3104
Monoisotopic: 249.126597495
Protein binding

64%

Groups Approved, Investigational
Therapeutic Class Ophthalmic Non-Steroid drugs
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Elpinan
Elpinan

Uses

Elpinan ophthalmic solution is used for the prevention of itching associated with allergic conjunctivitis.

Elpinan is also used to associated treatment for these conditions: Seasonal Allergic Conjunctivitis

How Elpinan works

Elpinan has a multiaction effect that inhibits the allergic response in 3 ways: 1. stabilizes mast cells by preventing mast cell degranulation to control the allergic response, 2. prevents histamine binding to both the H1- and H2-receptors to stop itching and provide lasting protection, and 3. prevents the release of proinflammatory chemical mediators from the blood vessel to halt progression of the allergic response.

Dosage

Elpinan dosage

The recommended dosage is one drop in each eye twice a day. Treatment should be continued throughout the period of exposure (i.e., until the pollen season is over or until exposure to the offending allergen is terminated), even when symptoms are absent.

Side Effects

Most frequently reported side effects are mild burning sensation, folliculosis, hyperemia, pruritus, cold symptoms and upper respiratory infections.

Precaution

For ophthalmic use only, Patients should be advised not to wear contact lenses if their eye is red.

Food Interaction

No interactions found.

Elimination Route

The absolute bioavailability of epinastine is about 40%.

Half Life

12 hours

Clearance

  • 56 L/hr [patients with allergic conjunctivitis receiving one drop of ELESTAT® ophthalmic solution in each eye twice daily for seven days]

Elimination Route

Elpinan is mainly excreted unchanged. The renal elimination is mainly via active tubular secretion.

Pregnancy & Breastfeeding use

Use in pregnancy: There are no adequate and well-controlled studies in pregnant women. Elpinan should be used during pregnancy only if the potential benefit justifies the potential risk to the fetus.

Use in lactation: It is not known whether Elpinan is excreted in human milk. Caution should be exercised when Elpinan is administered to a nursing mother.

Contraindication

Contraindicated in patients who are hypersensitive to Elpinan or to any of the components of Elpinan Hydrochloride.

Special Warning

Pediatric Use: Safety and effectiveness in pediatric patients below the age of 3 years have not been established.

Geriatric Use: No overall differences in safety or effectiveness have been observed between elderly and younger patients.

Storage Condition

Store in a cool and dry place, away from light. Keep out of reach of children.

Innovators Monograph

You find simplified version here Elpinan

Elpinan contains Epinastine see full prescribing information from innovator Elpinan Monograph, Elpinan MSDS, Elpinan FDA label

http://classyfire.wishartlab.com/tax_nodes/C0000000
http://classyfire.wishartlab.com/tax_nodes/C0000002
http://classyfire.wishartlab.com/tax_nodes/C0000293
http://classyfire.wishartlab.com/tax_nodes/C0000320
http://classyfire.wishartlab.com/tax_nodes/C0000320
http://classyfire.wishartlab.com/tax_nodes/C0000069
http://classyfire.wishartlab.com/tax_nodes/C0002448
http://classyfire.wishartlab.com/tax_nodes/C0000079
http://classyfire.wishartlab.com/tax_nodes/C0000375
http://classyfire.wishartlab.com/tax_nodes/C0003633
http://classyfire.wishartlab.com/tax_nodes/C0003152
http://classyfire.wishartlab.com/tax_nodes/C0004139
http://classyfire.wishartlab.com/tax_nodes/C0004557
http://classyfire.wishartlab.com/tax_nodes/C0004150
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=CHEBI:51032
http://www.hmdb.ca/metabolites/HMDB0014889
http://www.genome.jp/dbget-bin/www_bget?drug:D01713
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?cid=3241
https://pubchem.ncbi.nlm.nih.gov/summary/summary.cgi?sid=46509056
https://www.chemspider.com/Chemical-Structure.3128.html
http://www.bindingdb.org/bind/chemsearch/marvin/MolStructure.jsp?monomerid=50131441
https://mor.nlm.nih.gov/RxNav/search?searchBy=RXCUI&searchTerm=39684
https://www.ebi.ac.uk/chebi/searchId.do?chebiId=51032
https://www.ebi.ac.uk/chembldb/index.php/compound/inspect/CHEMBL1106
http://bidd.nus.edu.sg/group/cjttd/ZFTTDDRUG.asp?ID=DAP001074
http://www.pharmgkb.org/drug/PA164764489
http://www.rxlist.com/cgi/generic3/elestat.htm
https://www.drugs.com/cdi/epinastine.html
http://www.pdrhealth.com/drug_info/rxdrugprofiles/drugs/ele1680.shtml
https://en.wikipedia.org/wiki/Epinastine
*** Taking medicines without doctor's advice can cause long-term problems.
Share